8-Hydroxy-5,7-dinitronaphthalene-2-sulfonic acid – (483-84-1)

famciclovir, 104227-87-4, Famvir, BRL-42810, Famciclovirum, 2-(2-(2-Amino-9H-purin-9-yl)ethyl)propane-1, 3-diyl diacetate, Famciclovirum [INN-Latin], BRL 42810, [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate, 2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate, FCV, CHEBI:4974, UNII-QIC03ANI02, QIC03ANI02, NSC-758921, Famciclovir (Famvir), DTXSID0023038, HSDB 8121, 1, 3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester), 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine, MFCD00866964, 2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1, 3-propanediol diacetate (ester), 9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine, DTXCID403038, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-1, 3-propanediol diacetate, NSC 758921, NCGC00095133-01, Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester, Famciclovir 100 microg/mL in Acetonitrile, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-1, 3-propanediol diacetate, Famciclovirum (INN-Latin), FAMCICLOVIR (MART.), FAMCICLOVIR [MART.], FAMCICLOVIR (USP-RS), FAMCICLOVIR [USP-RS], Oravir, FAMCICLOVIR (USP MONOGRAPH), FAMCICLOVIR [USP MONOGRAPH], C14H19N5O4, 2-(2-(2-AMINO-9H-PURIN-9-YL)ETHYL)-1, 3-PROPANEDIOL DIACETATE ESTER, 2-(acetoxymethyl)-4-(2-amino-4, 5-dihydro-9H-purin-9-yl)butyl acetate, 2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1, 3-propanediol diacetate (ester), 2-[2-(2-Amino-9H-purin-9-yl)ethyl]trimethylene diacetate 2-[2-(2-Amino-9H-purin-9-yl)ethyl]trimethylene diacetate, SMR000466375, Famvir (TN), CAS-104227-87-4, SR-01000759358, 2-((acetyloxy)methyl)-4-(2-amino-9H-purin-9-yl)butyl acetate, Famciclovir [USAN:INN:BAN], 1, 3-propanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, diacetate (ester), BRL42810, Famciclovirum (Latin), Famciclovir (Standard), Spectrum_000466, FAMCICLOVIR [MI], Spectrum2_001101, Spectrum3_001675, Spectrum4_000611, Spectrum5_001548, FAMCICLOVIR [INN], FAMCICLOVIR [JAN], FAMCICLOVIR [USAN], CHEMBL880, FAMCICLOVIR [VANDF], SCHEMBL2949, BSPBio_003489, FAMCICLOVIR [WHO-DD], KBioGR_001162, KBioSS_000946, MLS000759505, MLS001424115, MLS006011896, Famciclovir (JAN/USP/INN), SPECTRUM1505201, SPBio_001202, Famciclovir – Bio-X trade mark, Famciclovir, >=98% (HPLC), GTPL11629, KBio2_000946, KBio2_003514, KBio2_006082, KBio3_002709, [2-(acetoxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate, FAMCICLOVIR [ORANGE BOOK], J05AB09, S01AD07, GLXC-10567, HMS1922L09, HMS2051G22, HMS2090G10, HMS2093K12, HMS2232H09, HMS3262O08, HMS3370D14, HMS3393G22, HMS3656A04, HMS3715F03, Pharmakon1600-01505201, ALBB-027262, BCP21312, Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine, Tox21_111442, Tox21_500793, AK-120, BDBM50248001, CCG-39277, HY-17426R, NSC758921, s2467, STK623204, AKOS005556609, Tox21_111442_1, AB07547, AC-8066, CS-1357, DB00426, FF23220, KS-5020, NC00156, NCGC00095133-02, NCGC00095133-03, NCGC00095133-04, NCGC00095133-06, NCGC00095133-15, NCGC00261478-01, BF164441, HY-17426, SBI-0206743.P001, DB-014809, F0842, NS00009533, SW197536-3, D00317, EN300-120645, AB00639952-06, AB00639952-08, AB00639952_09, AB00639952_10, Q420186, BRL-42810 BRL42810 BRL 42810 Famciclovirum, SR-01000759358-4, SR-01000759358-5, 9-(4-Acetoxy-3-acetoxymethyl-1-butyl)-2-aminopurine, 9-(4-acetoxy-3-acetoxymethylbut-1-yl)-2-aminopurine, BRD-K45033733-001-02-3, BRD-K45033733-001-05-6, BRD-K45033733-001-11-4, BRD-K45033733-001-12-2, Z1530532759, 9-[4-acetoxy-3-(acetoxymethyl)butyl]-2-amino-9h purine, 2-(2-(2-Amino-9H-purin-9-yl)ethyl)-propane-1, 3-diyl diacetate, Famciclovir, United States Pharmacopeia (USP) Reference Standard, Famciclovir, Pharmaceutical Secondary Standard Certified Reference Material, 2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1, 3-propanediol diacetate ester 9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine 9-[4-Acetox y-3-(acetoxymethyl)butyl]-2-aminopurine, 2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1, 3-propanediol diacetate ester 9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine 9-[4-Acetox y-3-(acetoxymethyl)butyl]-2-aminopurine